This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

The Journal Science Again Recognizes Abbott As One Of The Top Employers In The Biotech And Pharmaceutical Industry





ABBOTT PARK, Ill., Sept. 21, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) today was again named one of the Top 20 Employers by the journal Science. Based on the views of working scientists, this prestigious annual survey identifies the most respected employers in the biotechnology and pharmaceutical industry.

Abbott ranked No. 15 overall, receiving high marks for important, quality research, social responsibility and employee loyalty. The complete rankings are available online and in the Oct. 19, 2012 issue of Science. This is the ninth time Abbott has been ranked among the top companies in the survey.

"Scientific innovation is the driving force behind Abbott's mission to discover new ways to help patients manage their health," said John Leonard, M.D., senior vice president, Pharmaceuticals, Research and Development, Abbott. "We strive to create an environment that values invention, creativity and collaboration, which helps top scientists to conduct important work while building interesting and meaningful careers at Abbott. We are honored by this recognition from the scientific community as a benchmark of our success."

Scientists working at Abbott are given opportunities to succeed, lead and grow in their careers through training, mentoring, networking groups and development programs. In addition, a number of internal recognition efforts, including chairman's awards, president's awards and patent/inventor awards, work to highlight scientific excellence and contribution throughout the company.

The company recognizes its most distinguished scientists and engineers with induction into the prestigious Volwiler Society. Established in 1985 and named for the late Ernest H. Volwiler, Ph.D., an internationally recognized scientist and former Abbott president and chairman of the board, the society encourages professional growth, and is meant to spur, recognize and showcase scientific innovation at Abbott.  Each year, the Volwiler Society issues "Outstanding Research" awards to the Abbott scientists and teams who have made significant contributions to their fields.

About the 2012 Science Survey

The annual survey polls biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics. Respondents to the web-based survey were asked to rate companies based on 23 characteristics, including leadership and direction, work culture/environment, and academic and intellectual challenge. The 2012 rankings were determined based on 4,276 survey responses from readers of Science and other survey invitees. The study was conducted and rankings were determined by an independent research organization.

Abbott Widely Recognized as a Great Place to Work

In addition to being recognized as a top employer by Science, Abbott has been honored by The Scientist magazine as a Top BioPharma Employer nine times since 2003. Abbott also has been honored for workplace leadership in more than 25 countries around the world. The company has been included on the Working Mother Best Companies list for 12 consecutive years, on DiversityInc magazine's list of the top companies for diversity for nine years, and Hispanic Business magazine's list of the Top Companies for Diversity Practices for six years. Additionally, FORTUNE has named Abbott as one of "America's Most Admired Companies" every year since the list's inception in 1983.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacturing and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs approximately 91,000 people and markets its products in more than 130 countries.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,563.30 -317.06 -1.88%
S&P 500 1,930.67 -39.40 -2.00%
NASDAQ 4,369.7730 -93.1290 -2.09%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs